Economic assessment of moxidectin for onchocerciasis elimination in Ghana

Summary

This study aims to examine the mass drug administration (MDA) for onchocerciasis elimination in Ghana districts supported by Sightsavers.

Main objectives

  • Assess epidemiological and economic impact of moxidectin MDA
  • Compare costs and outcomes of ivermectin and moxidectin strategies
  • Identify cost drivers
  • Model elimination timelines

Policy and practice implications

Findings will guide evidence-based decision-making on resource allocation and moxidectin deployment in national onchocerciasis elimination programmes.

Methodology

  • Economic evaluation
Study details
Start date
1 June 2026
Finish date
1 September 2026
Main contact
Guillaume Trotignon
Senior research associate
Partners
  • Ghana Health Services
  • University of Health and Allied Sciences
  • Medicines Development for Global Health
Funders
Countries